Chestal Cold and Cough
- Manufacturer
- Boiron | Boiron, Inc.
- Effective date
- 2025-01-16
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-06-01 02:31:28
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredients** (in each pellet)
Dulcamara 5C HPUS (0.09 mg)
Ferrum phosphoricum 9C HPUS (0.09 mg)
Hydrastis canadensis 9C HPUS (0.09 mg) (contains less than 10 -20 mg hydrastine and berberine alkaloids)
Kali bichromicum 9C HPUS (0.09 mg) (contains less than 10 -19 mg chromium)
Nux vomica 9C HPUS (0.09 mg) (contains less than 10 -20 mg strychnine alkaloids)
The letters "HPUS" indicate that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of the United States.
OTC - PURPOSE SECTION
Purpose*
Dulcamara 5C HPUS (0.09 mg) ... Relieves colds and coughs worsened by exposure to damp cold
Ferrum phosphoricum 9C HPUS (0.09 mg) ... Relieves colds with gradual onset, occasional minor sore throat, and dry, fitful cough
Hydrastis canadensis 9C HPUS (0.09 mg) ... Relieves colds and coughs associated with runny nose
Kali bichromicum 9C HPUS (0.09 mg) ... Relieves nasal discharge
Nux vomica 9C HPUS (0.09 mg) ... Relieves sneezing fits
INDICATIONS & USAGE SECTION
Uses*
temporarily relieves symptoms of the common cold such as:
- nasal and chest congestion
- fitful cough
- sneezing
- occasional minor sore throat
- runny or stuff nose
WARNINGS SECTION
Do not use if you are allergic to any of this product's ingredients.
OTC - ASK DOCTOR SECTION
Ask a doctor before use if you have
- severe sore throat that is accompanied or followed by fever, headache, rash, nausea, or vomiting
- persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
- cough that occurs with too much phlegm (mucus)
OTC - STOP USE SECTION
Stop use and ask a doctor if
- sore throat worsens or persists for more than 2 days
- cough or nasal congestion worsens or lasts for more than 5 days in children under 12 years of age or 7 days in adults, comes back, or is accompanied by fever, rash, or a persistent headache
- new symptoms occur. These could be signs of a serious condition.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. In case overdose, get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Directions
- Adults and children 4 years of age and older: At the onset of symptoms, dissolve 5 pellets under the tongue every 15 minutes for 1 hour. Then dissolve 5 pellets under the tongue every 6 hours. Decrease frequency with improvement.
- Children under 4 years: Ask a doctor.
INACTIVE INGREDIENT SECTION
lactose, sucrose
OTC - QUESTIONS SECTION
BoironUSA.com
Info@Boiron.com
1-800-BOIRON-1
(1-800-264-7661)
Made in France
Distributed by Boiron, Inc.
Newtown Square, PA 19073
SPL UNCLASSIFIED SECTION
- do not use if glued carton end flaps are open or if pellet dispenser seal is broken
- contains 0.25 g of sugar per dose
- retain carton for full drug facts
Turn tube upside down
Twist until 5 pellets are dispensed
Remove cap and pour pellets under the tongue
MULTI-SYMPTOM COLD & COUGH*
Nasal & Chest Congestion Cough Runny Nose*
- On-the-Go Cold & Cough Relief*
- Melts Under the Tongue
- Non-Drowsy
2 TUBES
APPROX. 80 PELLETS EACH
TOTAL 160 PELLETS
*CLAIMS BASED ON TRADITIONAL HOMEOPATHIC PRACTICE NOT ACCEPTED MEDICAL EVIDENCE. NOT FDA EVALUATED.
**C,K,CK, and X are homeopathic dilutions: see BoironUSA.com/info for details.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0220-9113-41 | Chestal Cold and Cough | 80 in 1 TUBE | PELLET | 80 | 3 | |
| 0220-9113-42 | Chestal Cold and Cough | 2 in 1 CARTON | PELLET | 2 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0220-9113 | CHESTAL COLD AND COUGH (SOLANUM DULCAMARA TOP, FERROSOFERRIC PHOSPHATE, GOLDENSEAL, POTASSIUM DICHROMATE, STRYCHNOS NUX-VOMICA SEED) PELLET [BOIRON] | 3 | Current NDC, 2 package rows | 20250119_2bd2f6ce-ce54-1945-e063-6294a90ad051.zip |
Products#
Every source-derived product name is available through these pages.
- Chestal Cold and Cough
- SOLANUM DULCAMARA TOP, FERROSOFERRIC PHOSPHATE, GOLDENSEAL, POTASSIUM DICHROMATE, STRYCHNOS NUX-VOMICA SEED
- SOLANUM DULCAMARA TOP
- POTASSIUM DICHROMATE
- DICHROMATE ION
- STRYCHNOS NUX-VOMICA SEED
- FERROSOFERRIC PHOSPHATE
- GOLDENSEAL
- SUCROSE
- LACTOSE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0220-9113 | 0220-9113-41, 0220-9113-42 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SOLANUM DULCAMARA TOP | KPS1B1162N | ACTIB |
| POTASSIUM DICHROMATE | T4423S18FM | ACTIB |
| STRYCHNOS NUX-VOMICA SEED | 269XH13919 | ACTIB |
| FERROSOFERRIC PHOSPHATE | 91GQH8I5F7 | ACTIB |
| GOLDENSEAL | ZW3Z11D0JV | ACTIB |
| SUCROSE | C151H8M554 | IACT |
| LACTOSE | J2B2A4N98G | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Chestal Cold and Cough | SOLANUM DULCAMARA TOP, FERROSOFERRIC PHOSPHATE, GOLDENSEAL, POTASSIUM DICHROMATE, STRYCHNOS NUX-VOMICA SEED | Boiron | 2bd2f6ce-ce54-1945-e063-6294a90ad051 | 2025-01-16 | Warnings | 0220-9113-42 0220-9113-41 0220-9113 00220911341 00220911342 2bdba74e-46bf-4934-e063-6294a90abba2 2bd2f6ce-ce54-1945-e063-6294a90ad051 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

